MannKind Prices Offering

February 3, 2012 11:54 AM |

MannKind (Nasdaq: MNKD) priced its public offering of more than 31 million units at $2.40 per unit. Shares of the biopharmaceutical dropped 32 cents to $2.15.  


Tags:

Search

About this Entry

This page contains a single entry by published on February 3, 2012 11:54 AM.

Threshold Jointly Develops TH-302 With Merck was the previous entry in this blog.

FDA Removes Partial Clinical Hold On Idenix's IDX184 is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12